Concepedia

Danna Yeerken

DY

Statistics

Publications

5

Citations

395

H-Index

5

Active since

2019

Affiliations

Peking University Cancer Hospital(Current)

Peking University

Chinese Academy of Medical Sciences & Peking Union Medical College

Ministry of Education

University of Hong Kong - Shenzhen Hospital

Danna Yeerken is an author at Peking University Cancer Hospital specializing in oncology, medicine, and molecular oncology.

Publications per year

2019–2023

5

Publications

5

A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma

Mengjiao Wu, Yan Wang, Di Yang et al. · EBioMedicine · 2019 · 252 citations · Full text

, , +17

CDK7-YAP-LDHD axis promotes D-lactate elimination and ferroptosis defense to support cancer stem cell-like properties

Mengzhu Lv, Ying Gong, Xuesong Liu et al. · Signal Transduction and Targeted Therapy · 2023 · 70 citations · Full text

, , +17

PFKP is transcriptionally repressed by BRCA1/ZBRK1 and predicts prognosis in breast cancer

Danna Yeerken, Ruoxi Hong, Yan Wang et al. · PLoS ONE · 2020 · 31 citations · Full text

, , +17

Nlp promotes autophagy through facilitating the interaction of Rab7 and FYCO1

Wenchang Xiao, Danna Yeerken, Li Jia et al. · Signal Transduction and Targeted Therapy · 2021 · 27 citations · Full text

, , +15

Defect of SLC38A3 promotes epithelial mesenchymal transition and predicts poor prognosis in esophageal squamous cell carcinoma

Rui Liu, Ruoxi Hong, Yan Wang et al. · Chinese Journal of Cancer Research · 2020 · 15 citations · Full text

, , +17

1–5 of 5